HONSUN (NANTONG) Co., Ltd. (hereinafter referred to as HONSUN or the Company) was established in January 2005 and is located in Nantong Economic and Technological Development Zone, Jiangsu Province. On April 20 of 2015, the company has been listed on the NEEQ (National Equities Exchange and Quotations), with stock abbreviation of HONSUN and stock code 832278. In June 2016, the company has been upgraded into innovation layer of the NEEQ, became one of the first listed companies as the selection and start public offering of stocks. On November 15 of 2021, the company became one of the first listed companies on the BSE (Beijing Stock Exchange).
Since its establishment, the company has been committed to home health management, mainly engaged in the research and development, production, and sales of homecare medical device and health care products. The main products are blood pressure monitoring, nebulizing therapy, home care, diagnosis device etc., such as blood pressure monitor, nebulizer , stethoscope, ENT，oral irrigator, nasal irrigator and so on.
Currently, HONSUN products have obtained many international certifications such as EU CE certified, US FDA approval, ISO 13485 and many certifications from the international market. These products have been exported to Europe, America, Asia, Africa and many global countries and regions. The products have strong competitiveness in the international market. In the domestic market, the company's self-owned brand "SCIAN" has also gained a certain market base and has been awarded honorary titles such as "Jiangsu Famous Brand Product" "Jiangsu Famous Trademark" and so on.
